Recent Headlines
Within Biotechnology
Colorado BioScience Association Launches Internship Program with Support of 11 Area Employers and Universities
The Education Committee of the Colorado BioScience Association (CBSA) is launching its new Internship Program with the support of 11 Founding Employers and the major universities in the state. Intern recruitment begins immediately through early spring 2012, with the first interns expected to be placed in positions by summer 2012. - November 10, 2011 - Colorado BioScience Association
Introducing BioDatomics - the Latest Bioinformatics & Computational Biology Platform
BioDatomics releases a new version of their computational biology analysis and visualization platform – a workstation version is now available for free download. - November 10, 2011 - BioDatomics
RayBiotech, Inc. Engages Industry Expert for Business Development & Growth Advisory Services
RayBiotech, Inc., today announced that it has engaged recognized industry expert, David A. Dodd of RiversEdge BioVentures LLC to work with the Company in the areas of Business Development and Strategic Growth Opportunities. - November 10, 2011 - RayBiotech, Inc
Prevtec microbia Closes a $4 Million Financing Round with North-American and European Investors
Prevtec microbia inc., a rapidly expanding Canadian biotech company developing innovative animal health technologies for the livestock industry, announced that it has closed a $4 million financing round from a global syndicate of financial and industry leaders. The proceeds will mostly be used to... - November 09, 2011 - Prevtec microbia inc.
SoBran Gives to Women and Children
A Special Thanksgiving for the Women and Children of Linda Vista Most people expect to spend Thanksgiving at home, surrounded by friends and family. For the women and children of Linda Vista, “home” has a very different meaning this year. Previously homeless, they will celebrate... - November 06, 2011 - SoBran, Inc.
Rudolf Coetzee Named Director of Business Development at BioPharm Systems
BioPharm Systems, a leading provider of clinical trial, data, and drug safety solutions, and a Gold level member of Oracle Partner Network (OPN), today announced that Rudolf Coetzee has been named director of business development for the Europe, Middle East and Africa region. Mr. Coetzee will be... - November 05, 2011 - BioPharm Systems
Rapid Spectrum Sensing for Cognitive Radio
Dr. Hongbin Li of Stevens Institute of Technology Wins Outstanding Paper Award at IEEE Africon 2011. - November 05, 2011 - Stevens Institute of Technology
Bioo Scientific Launched the NEXTflex™ ChIP-Seq Kit for Improved Genome Wide Analysis of DNA-Protein Interactions
Bioo Scientific announced the launch of the NEXTflex™ ChIP-Seq Kit which was designed to simplify the genome-wide profiling of DNA-protein interactions by improving the traditional ChIP-Seq protocol and offering flexible barcoding options to facilitate multiplexing. ChIP-seq analysis is... - November 04, 2011 - Bioo Scientific
Total Pipette Management (TPM) Makes Compliance Easy with Green Document Storage Solutions and 24/7 Access for Pipette Calibration Records
Pipette.com is excited to announce the availability of Total Pipette Management (TPM) an innovative software solution to manage all aspects of a pipette instrument population. TPM is best known for its uses with document management for pipette calibration. TPM stores calibration certificates... - November 04, 2011 - Accutek Laboratories
VP at OSO BioPharmaceuticals Elected to DCAT Board of Directors
Milton Boyer to serve three-year term at leading industry association. - November 03, 2011 - OSO BioPharmaceuticals Manufacturing, LLC
San Francisco Clinical Affairs Consulting Firm Rebrands as The Jon Block Group: Expanded Team, Enhanced Capabilities
Jon E. Block, Ph.D., Inc., an internationally recognized clinical affairs consulting firm based in San Francisco announced today it has rebranded as The Jon Block Group (www.JonBlockGroup.com). The Jon Block Group serves many of the world’s top medical device firms, providing senior-level... - November 02, 2011 - Jon Block Group
Mitegen Announces Mutual Distribution Agreements with XTalQuest Inc., Ltd.
Mitegen LLC, a provider of innovative consumables for X-ray diffraction, crystallography and protein crystallization to academic, pharmaceutical, industrial and government researchers around the world, announced that it has signed mutual distribution agreements with XTalQuest Inc., Ltd a Beijing based provider of high quality crystallization plates, screening solutions, and other products for crystallography. - November 01, 2011 - MiTeGen, LLC
Stevens Professor David J. Cappelleri Selected for National Academy of Engineering Symposium
One of 65 young engineering educators selected to participate in curriculum development workshop. - October 30, 2011 - Stevens Institute of Technology
Novus Biologicals Announces New CHD7 Antibody Made Using SDIX Genomic Antibody Technology™
Novus Biologicals announced today a new CHD7 antibody (catalog number NBP1-77393) for use in research on transcription regulation and CHARGE syndrome. This CHD7 antibody was made using SDIX Genomic Antibody TechnologyTM. CHD7 is an ATP-dependent chromatin remodeler that interacts closely with SOX2... - October 29, 2011 - Novus Biologicals
Colorado BioScience Association Hosts World Renowned Photographer Rick Guidotti for Keynote Presentation at Industry Awards Celebration in Denver
Registration is now open for the Colorado BioScience Association (CBSA) Annual Awards Dinner, featuring Keynote Presenter Rick Guidotti, world renowned photographer and co-founder of New York-based Positive Exposure. The CBSA awards event is Thursday, December 8, at the Embassy Suites in Downtown Denver. - October 27, 2011 - Colorado BioScience Association
New LDL and VLDL Receptor Antibodies Released
Novus Biologicals announced today the release of new LDL Receptor (NBP1-78159) and VLDL Receptor (NBP1-78162) antibodies. LDL and VLDL Receptors are similar cell-surface receptor proteins which mediate endocytosis of cholesterol-rich lipoproteins. Both receptors are critical to the lipid and... - October 27, 2011 - Novus Biologicals
Bedford Research Foundation Hosts Ninth Annual Activated Egg Symposium
The Bedford Research Foundation is hosting the ninth annual Activated Egg Symposium, a yearly event that brings together experts in the stem cell research community to discuss their work, and form collaborations. The foundation's director, Dr. Ann Kiessling is proud to announce that this year's keynote speaker is Dr. Janet Rossant of the University of Toronto. The event is on November 4th, 2011 from 8am to 7:30pm. - October 26, 2011 - Bedford Stem Cell Research Foundation
Novus Biologicals Announces New PAR1 Antibody
Novus Biologicals announced today a new Thrombin Receptor antibody (catalog number NBP1-71770) for use in wound healing and cancer research. Thrombin Receptor, also known as Protease activated receptor 1 (PAR1), is a G-protein-coupled receptor that functions in blood clotting. While Thrombin... - October 26, 2011 - Novus Biologicals
Nanion Opens New Branch in China
Today, Nanion announces the opening of yet another branch. To meet the needs of the rapidly expanding number of customers in China, the dedicated sales- and support team in Beijing now opens the doors to Nanion Technologies China. - October 26, 2011 - Nanion Technologies GmbH
PharmaJet FDA Regulatory Clearances on Its Needle-Free Injection Devices
PharmaJet has received two FDA 510(k) marketing clearances for its IM/SC injection technology. Below are the Indications For Use, cleared by the FDA. FDA 510(k) Number K111517: PharmaJet Stratis Needle-free Injection System: The PharmaJet Stratis Needle-free Injection System is intended to... - October 25, 2011 - PharmaJet, Inc.
Novus Biologicals Announces New SHDA Antibody Made Using SDIX Genomic Antibody Technology™
Novus Biologicals announced today a new SDHA Antibody (catalog number NBP1-71688) for use in hypoxia research. This SHDA antibody was made using SDIX Genomic Antibody TechnologyTM. Localized within the mitochondrial inner membrane, Succinate Dehydrogenase A (SDHA) is an important component in the... - October 23, 2011 - Novus Biologicals
Ascletis Hosts Ground Breaking Ceremony for China Headquarters Oct. 20
N.C. Gov. Bev Perdue And Zhao Hongzhu, Zhejiang Province Party Secretary, Spoke at Event for First Major Chinese Investor-Backed Drug Development Company Operating Both in the United States and China - October 22, 2011 - Ascletis
Semprus BioSciences Awarded $1 Million U.S. Army Grant to Develop "Anti-Biofilm Trauma Devices" for American Soldiers in Battle
Semprus BioSciences today announced it has received a $1 million grant from the U.S. Army Telemedicine & Advanced Technology Research Center (TATRC) to develop the world's first orthopedic devices designed to reduce biofilm formation, the foundation for most bacterial complications associated with medical device implants. - October 21, 2011 - Semprus BioSciences
Evolution Pipettes from Pipette.com Provide High Quality Instruments to Life Science Labs Looking to Stretch Grant Money
Pipette.com is excited to announce the availability of Evolution pipettes. Pipette instrument technology has evolved and Evolution Pipettes are reflective of the recent industry progression. Evolution pipettes are proudly made in the USA. Evolution pipettes are available in single channel,... - October 20, 2011 - Accutek Laboratories
Advanced Cancer Therapeutics CEO to Present Preclinical Data on Cancer Metabolism Drug at MidAmerica Healthcare Venture Forum
Advanced Cancer Therapeutics, LLC (ACT), a for-profit private company dedicated to bringing new anti-cancer therapies to market, today announced that Randall B. Riggs, President & CEO, has been selected to present at the 9th Annual MidAmerica Healthcare Venture Forum to be held at the... - October 20, 2011 - Advanced Cancer Therapeutics
BioPharm Systems Wins 2011 Innovation Award for Excellence in Technology from the Oracle Health Sciences User Group
The Excellence in Health Sciences Award recognizes organizations or individuals that have designed and implemented a significant advancement that has increased an organization’s operational efficiencies and best practices. - October 20, 2011 - BioPharm Systems
Novus Biologicals Announces New Dicer1 Antibody Made Using SDIX Genomic Antibody Technology™
Novus Biologicals announced today a new DICER1 antibody (catalog number NBP1-71691) for use in cell cycle and replication and cancer research. This DICER1 antibody was made using SDIX Genomic Antibody TechnologyTM. DICER1 is a ribonuclease that has been extensively shown to be related to cancer. - October 20, 2011 - Novus Biologicals
AnaSpec Introduces SensoLyte® Deubiquitination Assay Kit
AnaSpec, EGT Group, is pleased to introduce the SensoLyte® 440 Deubiquitination Assay Kit. This kit provides a convenient assay for inhibitors/activators screening in deubiquitinylation or for continuous assay of enzyme activity. A natural substrate, ubiquitin, coupled with the AMC... - October 19, 2011 - AnaSpec, EGT Group
AnaSpec Includes Citrullinated Histone in GO® Peptides Collection
AnaSpec, the world’s largest provider of on-demand GO® peptides is pleased to offer a wide selection of Histone H1, H2A, H2B, H3 and H4 peptides, especially the H3 peptides. The rapidly expanding Histone GO® Peptides now include citrullinated sequences in addition to sequences that... - October 19, 2011 - AnaSpec, EGT Group
BioPharm Systems to Host Webinar on Applying Appropriate Clinical and Safety Technology to Mitigate Risk
Leading provider of Oracle's clinical trial, data, and safety solutions will provide an overview of business risks related to clinical and safety systems and will illustrate how the risks inherent in implementing complex CTMS and safety systems can be significantly reduced. - October 18, 2011 - BioPharm Systems
Novus Focuses on Supplying Quality Antibodies for Model Organism Research
Novus is a leading supplier of research antibodies that have been validated for use in model organisms, and they have recently expanded their selection of top quality reagents for Drosophila melanogaster, Caenorhabditis elegans, and Xenopus laevis. These three model organisms are commonly used in... - October 15, 2011 - Novus Biologicals
Stevens Mass Spectrometry Reveals Evolution of Insect Biochemistry
Dr. Attygalle provides new insight into how certain parasites locate host ants. - October 15, 2011 - Stevens Institute of Technology
MMS Announces Strategic Alliance with TransPerfect
MMS Holdings Inc. announces a strategic alliance with TransPerfect, the world's largest privately held provider of language services and technology, to offer translation and interpretation services to their clients across global clinical programs. These services are complimentary to those offered... - October 15, 2011 - MMS Holdings Inc.
Novus Announces Two Contest Winners
Novus Biologicals announced today the winners of two customer contests. First, the third quarter Novus Travel Grant winner is Dr. Toryn Poolman of the University of Manchester's School of Medicine, selected for his excellent review of our Glucocorticoid Receptor Antibody (NB300-610). Dr. Poolman... - October 14, 2011 - Novus Biologicals
New EpiPlus - Histone Modification Antibodies Announced Today
Novus Biologicals announced today the release of a new group of Epi-PlusTM antibodies for histone modification testing. Over the past several months, Novus has collaborated with 21st Century Biochemicals, a leading manufacturer of custom antibodies and peptides, to generate the most well validated... - October 12, 2011 - Novus Biologicals
WILEX Inc. and ALPCO Diagnostics Sign Marketing and Distribution Agreement for North America
WILEX AG announces that its wholly owned US subsidiary WILEX Inc., Cambridge, MA, USA, entered into a exclusive co-marketing and distribution agreement with American Laboratory Products Company Inc., (ALPCO Diagnostics) Salem, NH, USA, for the commercialization of the Serum HER-2/neu ELISA test in North America. - October 10, 2011 - ALPCO
Embedded Nanotechnology Devices for Monitoring National Infrastructure
Stevens engineers have demonstrated PZT nanofiber devices for use as embedded sensors. - October 08, 2011 - Stevens Institute of Technology
Optimizing Offshore Wind Energy Funded by DoE
Stevens Institute of Technology receives a Department of Energy grant to make wind a more viable solution for America's energy needs. - October 07, 2011 - Stevens Institute of Technology
Miami Surgery Practice Offers Discreet New STARR Weight-Loss Treatment
Bariatric surgeon Dr. Enrique Whittwell praises privacy and comfort of new procedure. - October 07, 2011 - TransEnterix
Two New Lamin A + C Antibodies Announced by Novus Biologicals
Novus Biologicals announced today two new Lamin A+C antibodies for use in epigenetic research and for certain cancer research. Lamins and lamin-associated proteins help shape the nucleus and provide a scaffold-type support system for chromosomes and replicating DNA to interact with epigenetic... - October 06, 2011 - Novus Biologicals
STARR Life Sciences® Awarded Us Patent for Pulse Oximeters That Work on Animals with Heart Rates in Excess of 450 Beats Per Minute
STARR Life Sciences Corp. announces the award of Patent #8,005,624 by the US Patent and Trademark Office for a small animal pulse oximeter that works on animals with heart rates above 450 bpm. - October 06, 2011 - STARR Life Sciences Corp.
New Gold Renewal Program from Pipette.com Restores Value to Previously Unusable Instruments in Life Science Labs
Pipette.com is excited to announce the release of a new pipette service and calibration program. The Gold Renewal Program is a new and exclusive program to Pipette.com. This program is designed to restore damaged and broken pipettes that are unable to be used because of their current condition. The... - October 06, 2011 - Accutek Laboratories
FyMed Reinforces Its Drug Development Pipeline with Novel Strategies in Personalized Medicine
FyMed, Inc., a biopharmaceutical company utilizing proprietary methodologies in evidence-based medicine for drug discoveries, recently announced plans for the strategic and operational reinforcements of their drug development pipeline through innovative approaches in personalized medicine. - October 06, 2011 - FyMed Inc
Novus Biologicals Announces New LAMP2 Antibody Made Using SDIX Genomic Antibody Technology™
Novus Biologicals announced today a new LAMP2 antibody (catalog number NBP1-71692) for use as a cell marker in autophagy signaling and cancer research. This LAMP2 antibody was developed using SDIX Genomic Antibody TechnologyTM. LAMP2 is a member of a family of membrane glycoproteins. Specifically,... - October 05, 2011 - Novus Biologicals
Bioo Scientific is Launching the NEXTflex-96™ DNA Barcodes to Significantly Increase NGS Throughput
Today Bioo Scientific announced the launch of the NEXTflex-96™ DNA Barcodes, which significantly increases next generation sequencing throughput by using barcoded indices to run multiple samples in parallel. The ability to increase the scale of next generation sequencing (NGS) is a critical... - October 01, 2011 - Bioo Scientific
New Group of EpiPlus Histone Modification Antibodies Released
Novus Biologicals announced today the release of a new group of Epi-PlusTM antibodies for histone modification testing. Over the past several months, Novus has collaborated with 21st Century Biochemicals, a leading manufacturer of custom antibodies and peptides, to generate the most well validated... - September 30, 2011 - Novus Biologicals
New Kit For Improved Protein Solubility Launched
Dilyx Biotechnologies, LLC announces the launch of the OptiResc Protein Aggregate Solubilization Kit, allowing research scientists to rescue inadvertently aggregated protein samples. The kit saves effort and money because it helps life the science researchers to continue work on protein samples,... - September 30, 2011 - Dilyx Biotechnologies LLC
NanoSort, Inc. Awarded Nearly $500k from the NCI to Advance the Detection and Capturing of Circulating Tumor Cells Using Two Distinct Novel Approaches
The National Cancer Institute (NCI), has awarded biomedical device start-up NanoSort, Inc. a 2 year, $297,000 Small Business Innovation Research (SBIR) grant and a 9-month, $198,000 contract. NanoSort will develop devices to detect circulating tumor cells (CTCs)—an emerging target in cancer... - September 30, 2011 - NanoSort
New Argentine Distributor Announced by Novus Biologicals
Novus Biologicals announced today a new distributor partnership in Argentina with Migliore Laclaustra, S.R.L. Argentina is a biotechnology leader in Latin America, with more than 80 multinational corporations and local companies currently operating nationally. The combination of a highly qualified... - September 29, 2011 - Novus Biologicals
AnaSpec Offers Industry’s First Anti-MOG ELISA Assay Kits
AnaSpec is pleased to be the first in the industry to provide a whole suite of reagents and assay kits for the advancement of MS research. This includes MOG proteins, peptides, antibodies and assay kits. Myelin Oligodendrocyte Glycoprotein (MOG), a protein with a molecular weight of 26- to 28-kDa,... - September 29, 2011 - AnaSpec, EGT Group